Effects of Sacubitril-Valsartan in Heart Failure With Preserved Ejection Fraction in Patients Undergoing Peritoneal Dialysis

Aims: The effect of the angiotensin receptor–neprilysin inhibitor (ARNI) sacubitril-valsartan in patients with heart failure with preserved ejection fraction (HFpEF) remains unclear, and data on ARNI treatment in peritoneal dialysis (PD) patients are lacking. The present study was designed to assess...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Sha, Xu, Zhenjian, Lin, Baojuan, Chen, Junzhe, Huang, Qiuyan, Xu, Yanchun, Xu, Anping, Chen, Yangxin, Tang, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255468/
https://www.ncbi.nlm.nih.gov/pubmed/34235161
http://dx.doi.org/10.3389/fmed.2021.657067

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255468/
https://www.ncbi.nlm.nih.gov/pubmed/34235161
http://dx.doi.org/10.3389/fmed.2021.657067

Ejemplares similares